Sarepta Therapeutics (SRPT) had the highest return in 2015 by a large-cap US stock, returning 164.6%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Sarepta Therapeutics (SRPT) | 2015 | 164.61% |
Neurocrine Biosciences (NBIX) | 2015 | 150.42% |
Netflix (NFLX) | 2015 | 132.71% |
Genmab A-S (GMAB) | 2015 | 123.37% |
Amazon (AMZN) | 2015 | 116.23% |
Coca-Cola Consolidated (COKE) | 2015 | 107.04% |
Trip Group Ltd ADR (TCOM) | 2015 | 101.43% |
Flutter Entertainment (FLUT) | 2015 | 94.9% |
NetEase (NTES) | 2015 | 84% |
Comfort Systems USA (FIX) | 2015 | 67.33% |
NVIDIA (NVDA) | 2015 | 66.43% |
HubSpot (HUBS) | 2015 | 66.01% |
EPAM Systems (EPAM) | 2015 | 64.58% |
Manhattan Associates (MANH) | 2015 | 61.75% |
Godaddy (GDDY) | 2015 | 60.3% |
Builders FirstSource (BLDR) | 2015 | 59.65% |
Global Payments (GPN) | 2015 | 58.89% |
Tyler Technologies (TYL) | 2015 | 58.42% |
Paylocity Holdng (PCTY) | 2015 | 55.19% |
Hormel Foods (HRL) | 2015 | 54.29% |
MSCI (MSCI) | 2015 | 53.2% |
VeriSign (VRSN) | 2015 | 52.65% |
ICON (ICLR) | 2015 | 52.26% |
Interactive Brokers (IBKR) | 2015 | 50.25% |
Churchill Downs (CHDN) | 2015 | 49.32% |
Large-cap stocks are treated as having a market cap of $10B+.
